HAL (France)open access
Prospective multicentre study evaluating ctDNA as a biomarker of residual disease after chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: NeckTAR-IN protocol
Oncology, Prognosis, 0, 1, Head and neck cancer
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 643355
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.